EUVIMEDAtrasti EUVIMED
Multizentrische StudieKohortenstudieOpen access · CC BY-NC 4.0

Antepartum vs postpartum amoxicillin oral challenge in pregnant patients with a reported penicillin allergy: A two‐center prospective cohort study

Jeffrey Man Hay Wong iD, Xiaoqing Liu, Raymond Mak, Stephanie C Erdle, Colin Barber, Julianne van Schalkwyk, Melissa Watt, Sudharsana Rao Ande, Dozie Ochulor, Chelsea Elwood, Vanessa Poliquin

Acta Obstetricia et Gynecologica Scandinavica · 2024

DOI: 10.1111/aogs.14964 ↗

At a glance

Multizentrische Studie in Acta Obstetricia et Gynecologica Scandinavica, 2024. Written by Jeffrey Man Hay Wong and 10 co-authors. Institution: Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada. Major MEDLINE topics: Drug Hypersensitivity, Amoxicillin, Anti-Bacterial Agents, Penicillins. Cited 4 times so far (Crossref); 20 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Canadian HIV Trials Network, Canadian Institutes of Health Research, B.C. Women's Hospital and Health Centre, Health Sciences Centre Foundation.

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Introduction

While 10% of pregnant individuals report a penicillin allergy, there is no established best practice for penicillin allergy delabeling in pregnancy. To better understand options for penicillin delabeling, we aimed to evaluate two penicillin allergy delabeling protocols in pregnancy regarding efficacy, adverse events, and patient satisfaction. Material and Methods From July 2019 to December 2022, we completed a two‐center prospective cohort study, where each site recruited pregnant patients over 24 weeks gestational age with a reported penicillin allergy. One center offered antepartum amoxicillin oral challenges, either directly or after negative skin testing (i.e., antepartum oral challenge site). Our other centers completed a two‐step approach with antepartum penicillin skin testing only and deferred oral challenges to the postpartum period (i.e., postpartum oral challenge site). Our primary outcome was the rate of penicillin allergy delabeling, defined as tolerating an antibiotic challenge with penicillin or amoxicillin. Univariate analyses were completed using chi‐squared, Fisher's exact, and Wilcoxon rank tests.

Results

During the study period, 276 pregnant patients were assessed, with 207 in the antepartum oral challenge site and 69 in the postpartum oral challenge site. Among the 204 patients who completed antepartum oral challenges, 201 (98%) passed without reactions. Deferring oral challenges to the postpartum period led to a loss of follow‐up for 37/53 (70%) of eligible individuals. Overall, 97% (201/207) of patients at the antepartum oral challenge site were delabeled from their penicillin allergy—compared to 38% (26/69) of patients referred to the postpartum oral challenge site ( p < 0.0001). Three antepartum oral challenge reactions were noted, including two mild cutaneous reactions and a case of transient abdominal discomfort.

Conclusions

Antepartum amoxicillin oral challenge is a more effective method to delabel pregnant patients from their penicillin allergy. Deferral of oral challenges to the postpartum period introduces a significant barrier for penicillin allergy delabeling.

Subjects

MeSH terms (MEDLINE)

Drug HypersensitivityAmoxicillinAnti-Bacterial AgentsPenicillinsHumansFemalePregnancyProspective StudiesAdultAdministration, OralSkin TestsPostpartum PeriodPrenatal CareCohort Studies

Author keywords

allergy and immunologyhypersensitivityobstetricsoral challengeoral provocationpenicillin allergypenicillin skin testpregnancy

Substances

AmoxicillinAnti-Bacterial AgentsPenicillins

Authors and institutions

  • Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada.
  • Department of Obstetrics, Gynecology and Reproductive Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Division of Allergy and Immunology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Division of Allergy and Immunology, Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.
  • Section of Allergy and Clinical Immunology, Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Women's Health Research Institute, BC Women's Hospital and Health center, Vancouver, British Columbia, Canada.

ORCID profiles: Jeffrey Man Hay Wong

Funding

  • Canadian HIV Trials Network, Canadian Institutes of Health Research
  • B.C. Women's Hospital and Health Centre
  • Health Sciences Centre Foundation
  • B.C. Women's Hospital and Health Center
  • Health Sciences Center Foundation

Cite

APA

Wong, J. M. H., Liu, X., Mak, R., Erdle, S. C., Barber, C., van Schalkwyk, J., Watt, M., Ande, S. R., Ochulor, D., Elwood, C., & Poliquin, V. (2024). Antepartum vs postpartum amoxicillin oral challenge in pregnant patients with a reported penicillin allergy: A two‐center prospective cohort study. Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.1111/aogs.14964

Vancouver

Wong JMH, Liu X, Mak R, Erdle SC, Barber C, van Schalkwyk J, et al. Antepartum vs postpartum amoxicillin oral challenge in pregnant patients with a reported penicillin allergy: A two‐center prospective cohort study. Acta Obstetricia et Gynecologica Scandinavica. 2024. doi:10.1111/aogs.14964

BibTeX
@article{Wong2024,
  author = {Wong, Jeffrey Man Hay and Liu, Xiaoqing and Mak, Raymond and Erdle, Stephanie C and Barber, Colin and van Schalkwyk, Julianne and Watt, Melissa and Ande, Sudharsana Rao and Ochulor, Dozie and Elwood, Chelsea and Poliquin, Vanessa},
  title = {Antepartum vs postpartum amoxicillin oral challenge in pregnant patients with a reported penicillin allergy: A two‐center prospective cohort study},
  journal = {Acta Obstetricia et Gynecologica Scandinavica},
  year = {2024},
  doi = {10.1111/aogs.14964}
}
Start for free →